Company intelligence
NMD Pharma A/S
A clinical-stage biotech company focused on developing life-changing therapies for neuromuscular diseases.
About NMD Pharma A/S
Mission NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease. Vision A future in which patients with neuromuscular disease live better and more independent lives. We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need. NMD Pharma is the leading company utilizing ClC-1 Cl- ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis. We have more than 25 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases. For more information, please visit the company website.
Verified activity
Signals from NMD Pharma A/S
5 published signals
Research & Knowledge
NMD Pharma A/S is sharing information on the science behind Charcot-Marie-Tooth disease and key unmet needs during CMT Awareness Month.
Reported by NMD Pharma A/S
Presence & Recognition
NMD Pharma A/S participated in the Muscular Dystrophy Association community as part of the MDAstrong campaign in September.
Reported by NMD Pharma A/S
People
NMD Pharma A/S welcomed Karina Jeppesen Morgen to the team in Aarhus for a one-year Lab Technician internship at Erhvervsakademi Aarhus | Business Academy Aarhus.
Reported by NMD Pharma A/S
Presence & Recognition
NMD Pharma A/S CEO Thomas Holm Pedersen will be joining industry leaders for a panel discussion at the 2026 ALBA – Aarhus Life science & Biotech Alliance summer event.
Reported by NMD Pharma A/S
People
NMD Pharma A/S welcomed Isabelle Zenklusen as an Associate Clinical Pharmacology Scientist based in Basel, Switzerland.
Reported by NMD Pharma A/S